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Introduction
Available data shows that dysphagia rate, secondary to
artificial airway and prolonged mechanical ventilation, in
critical tracheostomized patients is high (50-83%).
Dysphagia is directly related to bronchial aspirations
and respiratory infections. The rate of respiratory infec-
tions on tracheostomized patients is also very high
(Some series next 100%). The re-establishment of airway
using speaking valves allow the rehabilitation and
post-recovery of those disorders, as well as deglutition
and phonatory system rehabilitation.
Objectives
Determine the usefulness of speaking valve in preventing
respiratory nosocomial infections in critical tracheosto-
mized patients diagnosed of dysphagia secondary to artifi-
cial ariway.
Methods
Pilot phase of randomized multicenter controlled clinical
trial. From September 2014 until December 2014, the use
of speaking valve was randomized during mechanical
ventilation weaning-decannulation phase in critical
patients over 18 years, tracheostomized at ICU,
diagnosed of dysphagia secondary to artificial airway.
This study was carried out of simultaneous form in
7 units of intensive care including centers of the first,
second and third level.
Results
27 patients were included, 8 of which were excluded of
the record and later analysis because of problems of
protocols fulfillment. 19 included patients presented an
average of 60,46 years of age, and initial APACHEII
19,07. The average time of mechanical ventilation was
23,6 days. After ramdomisation 11 patients were treated
with speaking valve (SVgroup), and 8 by identical proto-
col without speaking valve (decannulation protocol
DPgroup). The incident of infections in the SVgroup
was 18,18% (2/11) and 37,5% (3/8) in the DPgroup.
Infections in the SVgroup were registered like tracheo-
bronquitis while in DPgroup as pneumonia. It is impor-
tant to indicate that all the patients included in this
study remained under absolute diet. Decannulation time
average was 4,4 days in the SVgroup and 6 days in the
DPgroup PD. Patients were decannulated when they ful-
filled strict criteria (in both groups) including disphagia
normalization. The mortality was 0 in the SVgroup and
3 in DPgroup.
There have not been registered side effects of the
speaking valve use. After detecting mistakes we have
proposed measures to avoid problems of follow-up of
protocols. The incorporation of the SV in the different
implied units has been easy and very well received.
Conclusions
Incident of respiratory infectious complications and mor-
tality was minor in the SVgroup. In the following months
it will continue the experimental phase of EDISVAL study
in order to know if these differences are attributable to
speaking valve use.
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